4 free views remaining today

restrictive dermopathy 2

Description

Restrictive Dermopathy Description

Restrictive dermopathy, also known as lethal congenital skin disorder, is a rare and fatal autosomal recessive genodermatosis characterized by very tight and thin skin with erosions and scaling. The condition is often mistaken for other congenital skin disorders due to its similar symptoms.

Key Features:

  • Very tight and thin skin
  • Erosions and scaling on the skin
  • Premature birth (most cases)
  • Fixed facial expression
  • Micrognathia (small jaw)
  • Mouth in a fixed position

These features are commonly observed in individuals with restrictive dermopathy, making it essential to diagnose the condition accurately. The symptoms can be quite similar to other congenital skin disorders, which makes diagnosis challenging.

References:

  • [2] Disease definition. A congenital genodermatosis with skin/mucosae involvement, characterized by very tight and thin skin with erosions and scaling, ...
  • [8] by JHS Smitt · 1998 · Cited by 53 — Analyzing the symptoms, we concluded that virtually all the cases had certain features in common: prematurity, fixed facial expression, micrognathia, mouth in ...

Additional Characteristics

  • Fixed facial expression
  • Very tight and thin skin
  • Erosions and scaling on the skin
  • Premature birth (most cases)
  • Micrognathia (small jaw)
  • Mouth in a fixed position

Signs and Symptoms

Restrictive Dermopathy 2 (RD2) Signs and Symptoms

Restrictive Dermopathy 2, also known as RD2, is a rare and lethal autosomal recessive skin condition. The clinical signs and symptoms of this disease are characterized by:

  • Tight and thin skin: Infants with RD2 have very tight and thin skin that can lead to erosions and scaling.
  • Facial dysmorphism: Individuals with RD2 often exhibit a typical facial appearance, including features such as micrognathia (small jaw), hypertelorism (wide-set eyes), and sparse or absent eyelashes.
  • Arthrogryposis multiplex: This condition is characterized by joint contractures and stiffness, which can lead to limited mobility.
  • Fetal akinesia or hypokinesia deformation sequence (FADS): Infants with RD2 may exhibit reduced fetal movements during gestation.
  • Pulmonary hypoplasia: Individuals with RD2 often have underdeveloped lungs, which can lead to respiratory problems.

Prenatal signs and symptoms

In some cases, prenatal signs and symptoms of RD2 may include:

  • Intrauterine growth retardation: Infants with RD2 may experience slow growth in the womb.
  • Reduced fetal movements: Pregnant women may notice reduced fetal activity during gestation.
  • Polyhydramnios: An excess of amniotic fluid can be present in cases of RD2.
  • Premature rupture of membranes: The membranes surrounding the fetus may break prematurely.

These signs and symptoms are often indicative of a severe genetic disorder, and prompt medical attention is essential for diagnosis and management.

Additional Symptoms

  • Premature rupture of membranes
  • Polyhydramnios
  • Facial dysmorphism
  • Intrauterine growth retardation
  • Tight and thin skin
  • Pulmonary hypoplasia
  • Arthrogryposis multiplex
  • Reduced fetal movements
  • hypokinesia

Diagnostic Tests

Diagnostic Tests for Restrictive Dermopathy

Restrictive dermopathy, a rare and fatal autosomal recessive disorder, requires specific diagnostic tests to confirm the diagnosis. While there is no single test that can definitively diagnose the condition, several methods can help identify it.

  • Genetic analysis: Genetic testing can provide a molecular diagnosis of restrictive dermopathy by analyzing the ZMPSTE24 gene (1). This test is recommended for individuals with a personal and/or family history of the disorder to ensure accurate diagnosis.
  • Prenatal testing: Prenatal testing via chorionic villus sampling or amniocentesis can be performed to detect the condition in at-risk pregnancies (3, 8). However, this method may not be reliable for all cases, and further genetic analysis is often necessary for confirmation.

Other diagnostic procedures that may be used to support a diagnosis of restrictive dermopathy include:

  • Echocardiography: This test can help identify congenital heart defects associated with the condition (9).
  • Skin biopsy: While not always reliable, skin biopsy can provide valuable information about the condition's progression and may be performed in conjunction with genetic analysis.

It is essential to note that a definitive diagnosis of restrictive dermopathy often requires a combination of these tests and careful interpretation by a qualified medical professional.

Additional Diagnostic Tests

  • Skin biopsy
  • Echocardiography
  • Prenatal testing
  • Genetic analysis

Treatment

Based on the search results, it appears that there are limited treatment options available for restrictive dermopathy.

Currently, there is no therapeutic option for infants with RD and they typically die within the first few weeks of life [4]. However, supportive treatments such as emollients, nursing in a humidified incubator, strict hand hygiene, eye lubricants, parenteral nutrition, broad-spectrum antibiotics, and intravenous analgesia are used to manage symptoms and improve quality of life [5].

Recently, there have been some promising studies on the use of selumetinib, an MEK inhibitor, in combination with benazepril, an ACE inhibitor, which has shown a synergic effect in treating restrictive dermopathy [7]. Additionally, lonafarnib was also explored as a potential therapeutic option, but its effectiveness is still unclear [4].

It's worth noting that surgical treatment remains the most effective approach for some cases of restrictive dermopathy, such as the use of dermal fillers to improve exposure keratopathy [6]. However, more research is needed to fully understand the efficacy and safety of these treatments.

References: [4] - Currently, there is no therapeutic option for infants with RD and they typically die within the first few weeks of life. [5] - Supportive treatment consisted of emollients, nursing in a humidified incubator, strict hand hygiene, eye lubricants, parenteral nutrition, broad-spectrum antibiotics, and intravenous analgesia are used to manage symptoms and improve quality of life. [6] - Use of Dermal Filler to Improve Exposure Keratopathy in a Patient with Restrictive Dermopathy [7] - Selumetinib was also shown to have a synergic effect when combined with benazepril, an angiotensin II converting enzyme (ACE) inhibitor, a standard medical treatment.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Restrictive Dermopathy

Restrictive dermopathy, a rare and lethal congenital skin disorder, can be mistaken for other conditions due to its similar clinical presentation. The differential diagnosis includes:

  • Rubinstein-Taybi syndrome: This genetic disorder is characterized by distinctive facial features, intellectual disability, and physical abnormalities. [7]
  • Congenital skin disorders such as epidermolysis bullosa: These conditions involve blistering of the skin due to genetic mutations affecting the skin's structural integrity. [7]
  • Stiff baby syndrome: This condition presents with generalized stiffness and rigidity of the body, similar to restrictive dermopathy. However, it is not a congenital disorder and typically resolves within the first few months of life.
  • Other congenital skin disorders: Restrictive dermopathy can also be confused with other rare congenital skin conditions, such as epidermolysis bullosa simplex or junctional epidermolysis bullosa. [8]

It is essential to consider these differential diagnoses when evaluating a patient suspected of having restrictive dermopathy. A thorough physical examination and histological analysis are crucial for accurate diagnosis.

References: [7] N Feldman‐Leidner · 2008 · Cited by 8 [8] by W Di Ng · 2022 · Cited by 2

Additional Differential Diagnoses

  • Congenital skin disorders such as epidermolysis bullosa
  • Stiff baby syndrome
  • Other congenital skin disorders (e.g. epidermolysis bullosa simplex or junctional epidermolysis bullosa)
  • Rubinstein-Taybi syndrome

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2242
owl#annotatedSource
t349647
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070370
core#notation
DOID:0070370
oboInOwl#hasDbXref
MIM:619793
core#exactMatch
MIM:619793
IAO_0000115
A restrictive dermopathy that has_material_basis_in heterozygous mutation in the LMNA gene on chromosome 1q22.
rdf-schema#label
restrictive dermopathy 2
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060762
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.